Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Publisher
Biomedicines(1)
Nature(1)
New Microbes and New Infections(1)
The Journal of infectious diseases(1)
Área temáticas
Enfermedades(3)
Farmacología y terapéutica(1)
Medicina forense; incidencia de enfermedades(1)
Año de Publicación
2022(4)
Characterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection
ArticleAbstract: BACKGROUND: We have recently revealed that the severe acute respiratory syndrome coronavirus 2 (SARSPalabras claves:covid-19, Immune resistance, Mu variant, SARS-COV-2Autores:Erika B. Muñoz, Kosugi Y., Paul Andres Cardenas, Paul Cardenas, Sato K., Shirakawa K., Takaori-Kondo A., Uriu K., Verónica BarragánFuentes:googlescopusEvaluation of the Anti-Leishmania mexicana and -Trypanosoma brucei Activity and Mode of Action of 4,4′-(Arylmethylene)bis(3-methyl-1-phenyl-1H-pyrazol-5-ol)
ArticleAbstract: Trypanosomiasis and leishmaniasis are neglected infections caused by trypanosomatid parasites. The fPalabras claves:4,4′-(arylmethylene)bis(1H-pyrazol-5-ols), Adme, drug-like, LEISHMANIA, redox biosensor, TrypanosomaAutores:Comini M.A., Erika B. Muñoz, Jorge Hebkp_redia-Moya, Medeiros A., Olalla Barreiro-Costa, Patricio Rojas-Silva, Quiroga Lozano C.Fuentes:scopusFirst case of within-host co-infection of different SARS-CoV-2 variants in Ecuador
ArticleAbstract: Background: COVID-19 infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2Palabras claves:co-infection, covid19, Genome sequencing, NGS, SARS-COV-2Autores:Andrade-Molina D.M., Belén Prado-Vivar, Bernardo M. Gutierrez, Erika B. Muñoz, Fernandez-Cadena J.C., Gabriel Antonio Trueba Piedrahita , Gabriel Morey León, Juan José Guadalupe, Mateo Carvajal, Michelle Grunauer Andrade, Mónica Becerra-Wong, Patricio Rojas-Silva, Paul Andres Cardenas, Paul Cardenas, Rosa Bayas, Stefanie Proaño, Sully Márquez, Verónica BarragánFuentes:googlescopusAltered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
ArticleAbstract: The SARS-CoV-2 Omicron BA.1 variant emerged in 20211 and has multiple mutations in its spike proteinPalabras claves:Autores:Abdullahi A., Baker S., Belén Prado-Vivar, Bernardo M. Gutierrez, Betancourt A., Bower G., Brevini T., Bucke A., Bullman B., Calder J., Canna L., Charles O.J., Cossetti C., de Sa A., Domingo J., Dougan G., Dunmore B.J., Elmer A., Emma Jones, Epping M., Erika B. Muñoz, Fatihi S., Fawke S., Ferreira I.A.T.M., Fuller S., Gabriel Antonio Trueba Piedrahita , Gerber P.P., Gleadall N., Goonawardane N., Graf S., Grenfell R., Harris J., Hess C., Hewitt S., Hinch A., Hodgson J., Huang C., Hunter K., Ikeda T., Jackson S., Jarvis I., Jose S., Juan José Guadalupe, Kemp S.A., Kennet J., Kimura I., Kingston N., Kourampa J., Krishna B., Kuramochi J., Legchenko E., Lehner P.J., Lyons P.A., Mallery D.L., Manuel Eduardo Baldeón, Martin J., Matara C., Mateo Caravajal, Matheson N.J., Maxwell P., Meadows A., Meng B., Mescia F., Michelle Grunauer Andrade, Mitsunaga S., Mónica Becerra-Wong, Nice F., Omarjee O., Ouwehand W.H., O’Brien C., O’Donnell C., Papa G., Patricio Rojas-Silva, Paul Andres Cardenas, Paul Cardenas, Perera M., Pointon L., Potts M., Price J., Publico C., Rastall R., Rathore S., Ribeiro C., Richoz N., Romashova V., Rowlands J., Ruffolo V., Saito A., Saunders C., Shaw A., Shih J., Shirakawa K., Stefanucci L., Strezlecki M., Sully Márquez, Summers C., Sutcliffe R., Takaori-Kondo A., Tan T.S., Thaventhiran J.E.D., Tilly T., Tong Z., Tordesillas H., Toshner M., Toyoda M., Treacy C., Turner L., Ueno T., Verónica Barragán, Weekes M.P., Wood J., Wylot M., Yamasoba D., Zepeda S.K.Fuentes:googlescopus